STOCK TITAN

SciSparc Ltd. (SPRC) Financials

SPRC NASDAQ
FY2025 annual
Revenue $856K -34.5% YoY
Net Income -$12.6M n/m YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow -$4.1M n/m YoY
Market Cap $749K as of Oct 26, 2026
Price / Sales 0.9x on $856K revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.1x on $5.1M equity, FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SPRC SEC filings page.

SciSparc Ltd. (SPRC) reported $856K in revenue for fiscal year 2025, down 34.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SPRC FY2025

SciSparc remains a development-stage business: shrinking revenue coexists with recurring cash outflows and financing-dependent support.

From FY2024 to FY2025, the reported net loss widened to $12.6M even as operating cash outflow narrowed to $4.1M. That divergence, alongside $8.6M of FY2025 financing cash flow, makes earnings quality difficult to read as operating performance alone; financing supplied the main cash support rather than operating receipts.

In FY2024, R&D of $1.7M exceeded revenue of $1.3M, making development spending larger than the sales base. The supplied R&D proportion was 130.7%, so reported sales were not yet carrying the development cost structure.

FY2025 liabilities were $2.5M against $7.6M of assets, so the balance sheet was not primarily debt-funded. Yet the current ratio was 2.4x after current liabilities increased 61.0% from FY2024, pointing to a tighter short-term cushion than the asset total alone suggests; reported liquidity equaled 13.3 months of annual operating outflow.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

SciSparc Ltd. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

SciSparc Ltd. passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality No Cash Backing
N/A

SciSparc Ltd. reported a net loss of $12.6M while operations used $4.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$856K
YoY-34.5%

SciSparc Ltd. generated $856K in revenue in fiscal year 2025. This represents a decrease of 34.5% from the prior year.

Net Income
-$12.6M
YoYn/m

SciSparc Ltd. reported a net loss of $12.6M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EBITDA

Not reported for fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
$4.6M
YoY+198.1%
5Y CAGR+18.7%

SciSparc Ltd. held $4.6M in cash against $9K in long-term debt as of fiscal year 2025.

Shares Outstanding
365,444

SciSparc Ltd. had 365,444 shares outstanding in fiscal year 2025.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-244.1%
YoY-167.0pp
5Y change-491.3pp

SciSparc Ltd.'s ROE was -244.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 167.0 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

SPRC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRC annual income statement
MetricFY2520-FFY246-KFY236-KFY226-KFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Revenue$856K-34.5%$1.3M-54.6%$2.9M+113.7%$1.3MN/AN/AN/AN/AN/AN/A
Cost of RevenueN/A$800K+17.1%$683K+112.1%$322KN/AN/AN/AN/AN/AN/A
Gross ProfitN/A$506K-77.0%$2.2M+114.2%$1.0MN/AN/AN/AN/AN/AN/A
R&D ExpensesN/A$1.7M+4.0%$1.6M-41.5%$2.8M+40.9%$2.0M+206.6%$649K-60.4%$1.6M-39.5%$2.7M+39.5%$1.9M+162.6%$740K
Operating IncomeN/A-$7.3Mn/m-$6.8Mn/m-$8.3Mn/m-$5.8Mn/m-$3.3Mn/m-$4.1Mn/m-$7.2Mn/m-$5.8Mn/m-$2.0M
EBITDAN/A-$6.8Mn/m-$6.3Mn/m-$8.1Mn/m-$5.7Mn/m-$3.1Mn/m-$3.9Mn/m-$7.1Mn/m-$5.7Mn/m-$2.0M
Interest ExpenseN/A$353K-66.5%$1.1M-47.6%$2.0M+9490.5%$21K-97.6%$872K+29.0%$676K+458.7%$121K-75.4%$491K+6037.5%$8K
Income Tax-$14Kn/m-$14K-163.6%$22K+57.1%$14KN/AN/AN/A-$60KN/AN/A
Net Income-$12.6Mn/m-$6.3Mn/m-$5.1Mn/m-$2.6Mn/m-$5.8M-263.8%$3.5M-24.6%$4.7M-28.3%$6.5M+4.6%$6.2M+213.3%$2.0M
EPS (Basic)N/A$26.88$303.03$0.31$73.58$0.10$0.64-46.7%$1.20N/AN/A
EPS (Diluted)N/A$26.88$303.03$311.22$73.58$0.11$0.64-46.7%$1.20N/AN/A
Diluted Shares (Avg)124,185277,38019,4138,37979,000N/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: SG&A Expenses.

SPRC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRC annual balance sheet
MetricFY2520-FFY246-KFY236-KFY226-KFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Total Assets$7.6M-26.3%$10.3M-7.5%$11.2M+5.4%$10.6M+6.9%$9.9M+287.2%$2.6M+121.9%$1.2M-74.7%$4.6M-52.3%$9.6M+668.4%$1.2M
Current Assets$5.4M-27.5%$7.5M+16.4%$6.4M+42.9%$4.5M-54.1%$9.8M+285.3%$2.5M+167.0%$955K-60.7%$2.4M-74.4%$9.5M+1081.2%$804K
Cash & Equivalents$4.6M+198.1%$1.5M-25.8%$2.1M-41.9%$3.6M-48.0%$6.9M+253.3%$1.9M+123.7%$870K-41.4%$1.5M-83.8%$9.2M+1260.2%$676K
Short-Term Investments$0N/AN/AN/AN/AN/AN/AN/AN/AN/A
Inventory$75K-33.6%$113K-84.8%$742K+11.1%$668KN/AN/AN/AN/AN/AN/A
Accounts ReceivableN/AN/AN/A$77KN/AN/AN/AN/AN/AN/A
Long-Term Investments$0N/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$2.5M+12.9%$2.2M-38.5%$3.6M-14.1%$4.2M+134.1%$1.8M+56.9%$1.1M-0.8%$1.1M-73.9%$4.4M+271.7%$1.2M+75.1%$672K
Current Liabilities$2.3M+61.0%$1.4M-10.9%$1.6M-62.2%$4.2M+136.5%$1.8M+55.3%$1.1M+8.1%$1.0M-76.7%$4.5M+280.9%$1.2M+75.1%$672K
Non-Current Liabilities$222K+2366.7%$9K-99.5%$2.0Mn/m$0-100.0%$18Kn/m$0-100.0%$101Kn/m-$108Kn/m$0n/m$0
Long-Term Debt$9KN/AN/AN/AN/AN/A$50KN/AN/AN/A
Total Equity$5.1M-36.9%$8.2M+7.1%$7.6M+18.1%$6.4M-20.8%$8.1M+469.3%$1.4M+10114.3%$14K-92.4%$185K-97.8%$8.4M+1364.0%$573K
Retained Earnings-$87.2Mn/m-$75.0Mn/m-$68.7Mn/m-$63.6Mn/m-$61.0Mn/m-$55.2Mn/m-$51.7Mn/m-$46.9Mn/m-$38.4Mn/m-$32.1M

Not reported in any period shown, so not listed: Goodwill.

SPRC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRC annual cash flow statement
MetricFY2520-FFY246-KFY236-KFY226-KFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Operating Cash Flow-$4.1Mn/m-$5.1Mn/m-$5.9Mn/m-$7.9Mn/m-$5.1Mn/m-$4.3Mn/m-$4.7Mn/m-$7.1Mn/m-$4.6Mn/m-$1.5M
Depreciation & Amortization$234K-51.5%$482K-10.4%$538K+187.7%$187K+466.7%$33K-79.9%$164K-8.4%$179K+21.8%$147K+2840.0%$5K+25.0%$4K
Capital ExpendituresN/AN/AN/A$8K-77.1%$35KN/A$1K-94.1%$17K-61.4%$44K+1000.0%$4K
Free Cash FlowN/AN/AN/A-$7.9Mn/m-$5.1MN/A-$4.7Mn/m-$7.1Mn/m-$4.6Mn/m-$1.5M
Investing Cash Flow-$1.4Mn/m-$1.6Mn/m-$4.1Mn/m-$7.1Mn/m-$70K-391.7%$24K-98.1%$1.3Mn/m-$2.1Mn/m-$53Kn/m-$5K
Financing Cash Flow$8.6M+38.7%$6.2M-27.0%$8.5M-27.5%$11.7M+16.3%$10.1M+87.7%$5.4M+91.1%$2.8M+82.6%$1.5M-88.3%$13.2M+2231.9%$565K

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

SPRC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRC annual financial ratios
MetricFY2520-FFY246-KFY236-KFY226-KFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Gross MarginN/A38.7%-37.5pp76.3%+0.2pp76.1%N/AN/AN/AN/AN/AN/A
Operating MarginN/A-560.2%-236.7%-615.2%N/AN/AN/AN/AN/AN/A
Net Margin-1467.8%-481.2%-177.9%-192.4%N/AN/AN/AN/AN/AN/A
Return on Equity-244.1%-167.0pp-77.1%-9.8pp-67.3%-27.1pp-40.2%+30.9pp-71.1%-318.3pp247.2%-33224.2pp33471.4%+29939.5pp3531.9%+3457.5pp74.4%-273.4pp347.8%
Return on Assets-164.8%-104.1pp-60.7%-14.9pp-45.8%-21.4pp-24.4%+33.9pp-58.4%-196.4pp138.0%-268.0pp406.1%+262.8pp143.3%+78.0pp65.3%-94.8pp160.1%
Current Ratio2.41-3.0x5.36+1.3x4.10+3.0x1.09-4.5x5.59+3.3x2.25+1.3x0.91+0.4x0.54-7.5x8.07+6.9x1.20
Debt-to-Equity0.00N/AN/AN/AN/AN/A3.57N/AN/AN/A
Liabilities-to-Equity0.48+0.2x0.27-0.2x0.47-0.2x0.64+0.4x0.22-0.6x0.79-80.6x81.43+57.8x23.65+23.5x0.14-1.0x1.17
Asset Turnover0.110.0x0.13-0.1x0.26+0.1x0.13N/AN/AN/AN/AN/AN/A
FCF MarginN/AN/AN/A-588.3%N/AN/AN/AN/AN/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
SciSparc Ltd. SPRC FY2025 $856K -$12.6M N/A $749K —
PMGC Holdings Inc. ELAB FY2025 $590K -$7.7M N/A $2.1M —
Revelation Biosciences, Inc. REVB FY2025 N/A -$8.9M N/A $2.0M —
Indaptus Therapeutics, Inc. INDP FY2025 N/A -$20.8M N/A $445.0M —
PROTAGENIC THERAPEUTICS PTIX FY2026 $0 $1.4M N/A $1.2M —

Frequently Asked Questions

What is SciSparc Ltd.'s annual revenue?

SciSparc Ltd. (SPRC) reported $856K in total revenue for fiscal year 2025. This represents a -34.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SciSparc Ltd.'s revenue growing?

SciSparc Ltd. (SPRC) revenue declined by 34.5% year-over-year, from $1.3M to $856K in fiscal year 2025.

Is SciSparc Ltd. profitable?

No, SciSparc Ltd. (SPRC) reported a net loss of $12.6M in fiscal year 2025.

As of fiscal year 2025, SciSparc Ltd. (SPRC) had $4.6M in cash and equivalents against $9K in long-term debt.

SciSparc Ltd. (SPRC) has a return on equity of -244.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

SciSparc Ltd. (SPRC) recorded an outflow of $4.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

SciSparc Ltd. (SPRC) had $7.6M in total assets as of fiscal year 2025, including both current and long-term assets.

SciSparc Ltd. (SPRC) had 365,444 shares outstanding as of fiscal year 2025.

SciSparc Ltd. (SPRC) had a current ratio of 2.41 as of fiscal year 2025, which is generally considered healthy.

SciSparc Ltd. (SPRC) had a debt-to-equity ratio of 0.00 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

SciSparc Ltd. (SPRC) had a liabilities-to-equity ratio of 0.48 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

SciSparc Ltd. (SPRC) had a return on assets of -164.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

SciSparc Ltd. (SPRC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $749K as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

SciSparc Ltd. (SPRC) trades at 0.9x sales, its market capitalization divided by $856K revenue, FY2025. The market capitalization is $749K as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, SciSparc Ltd. (SPRC) held $4.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $4.1M over that year. Dividing the one by the other, the reported balance equals about 13 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

SciSparc Ltd. (SPRC) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SciSparc Ltd. (SPRC) reported a net loss of $12.6M while operations used $4.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top